Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using intravenous Rho (D) immune globulin

Transfusion Medicine Reviews

Volumn 15, Issue 1, 2001, Pages 67-76

  Sandler, S Gerald ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

AGAMMAGLOBULINEMIA; ALLOIMMUNIZATION; CONFERENCE PAPER; DRUG INDICATION; DRUG MECHANISM; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOPROPHYLAXIS; NEWBORN HEMOLYTIC DISEASE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 0035175894     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1053/tmrv.2001.19953     Document Type: Conference Paper

References (67)

1. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in children
2. Die Klindlichen Thrombocytopenien
3. High-dose intravenous IgG in adults with autoimmune thrombocytopenia
4. Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomy
5. High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura
6. Effect of intravenous immunoglobulin in immune thrombocytopenia: Competitive inhibition of reticuloendothelial system function by sequestration of autologous red blood cells?
7. Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rho[D])
8. Effect of IgG anti-Rho (D) in adult patients with chronic autoimmune thrombocytopenia
9. Safety profile of WinRho anti-D
10. WinRho: Rh immune globulin prepared by ion exchange for intravenous use
11. Column ion-exchange preparation and characterization of an Rh immune globulin (WinRho) for intravenous use
12. Investigations into the application of tri(n-butyl)phosphate/detergent mixtures to blood derivatives
13. Value of virus filtration as a method for improving the safety of plasma products
14. Detection of multiple passively acquired alloantibodies following infusions of intravenous Rh immune globulin
15. Immunoglobulin A concentrations in commercial immune globulins
16. IgA anaphylactic transfusion reactions
17. WinRho SDF/Rho (D) Immune Globulin Intravenous (Human), Product Information
18. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin
19. Possible mechanisms of intravenous immunoglobulin treatment in childhood idiopathic thrombocytopenic purpura (ITP)
20. Intravenous immunoglobulin and Rh immunoglobulin as immunomodulators of autoimmunity to blood elements
21. Immunologic effects of anti-D (WinRho-SD) in children with immune thrombocytopenic purpura
22. The treatment of patients with autoimmune thrombocytopenia with intravenous IgG-anti-D (International Forum)
23. Intravenous anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity and mechanism of effect
24. Intravenous anti-D treatment of immune thrombocytopenic purpura: Experience in 272 patients
25. Treatment of chronic autoimmune thrombocytopenic purpura with monoclonal anti-D
26. Anti-Rh immunoglobulin therapy for human immunodeficiency virus-related immune thrombocytopenic purpura
27. Anti-rhesus antibodies, immune thrombocytopenia, and human immunodeficiency virus infection
28. Efficacy of rhesus antibodies (anti-Rho[D]) in autoimmune thrombocytopenia: Correlation with response to high-dose IgG and the degree of haemolysis
29. Persistence and selectivity of the immune phagocytosis inhibition by major histocompatibility complex antibodies
30. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies
31. Macrophage-mediated cell destruction
32. Anti-D: Mechanisms of action
33. The spleen and splenectomy in immune (idiopathic) thrombocytopenic purpura
34. Treatment of childhood idiopathic thrombocytopenic purpura with rhesus antibodies (anti-D)
35. Randomized trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura
36. Intravenous anti-D immunoglobulin for childhood acute immune thrombocytopenic purpura
37. Rapid and complete response of immune thrombocytopenic purpura to a single injection of Rhesus anti-D immunoglobulin
38. Efficacy of Rhesus antibodies (anti-Rho(D)) in autoimmune thrombocytopenia: Correlation of response to high dose IgG and the degree of haemolysis
39. The treatment of chronic idiopathic thrombocytopenia with anti-D (Rho) immunoglobulin: Its effectiveness, safety and mechanism of action
40. A multi-center study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D
41. Sternid-free interval with anti-D in chronic idiopathic thrombocytopenic purpura
42. Anti-D immunoglobulin in the treatment of idiopathic thrombocytopenic purpura
43. Successful anti-D immunoglobulin therapy in refractory chronic idiopathic thrombocytopenic purpura showing reduction in thrombocytes even after splenectomy
44. Intramuscular anti-D immunoglobulins for home treatment of chronic immune thrombocytopenic purpura
45. Treatment of chronic childhood immune thrombocytopenic purpura with intramuscular anti-D immunoglobulins
46. Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpura
47. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rho(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients
48. Intravenous anti-D treatment of immune thrombocytopenic purpura
49. In patients with ITP, does 75 μg/kg of IV anti-D increase the platelet count faster than 50 μg/kg?
50. Treatment options for chronic idiopathic (immune) thrombocytopenic purpura
51. The cost of treating immune thrombocytopenic purpura using intravenous Rh immune globulin versus intravenous immune globulin
52. Use of Rh immune globulin/ASCP practice parameter
53. Rho(D) Immune globulin IV for the prevention of Rh isoimmunization and for the treatment of ITP
54. Rh(D) immunization after massive transfusion of Rh(D)-positive blood
55. Suppression of Rh immunization by anti-Rh
56. Prevention of maternal immunization after accidental transfusion of D(Rho)-positive blood
57. Failure to prevent Rhesus immunization with Rhesus immune globulin after incompatible blood transfusion
58. Evaluating the need for Rh immune globulin in some unusual situations
59. Resolution by erythrocytapheresis of the exposure of an Rh-negative person to Rh-positive cells: An alternative treatment
60. Successful prevention of post-transfusion alloimmunization by intravenous Rho (D) immune globulin (WinRho SD)
61. Formation of red cell antibodies in response to platelet transfusions
62. Rh-incompatible platelet transfusions: Risks and consequences of sensitizing immuno-suppressed patients
63. Rh-incompatible platelet transfusion therapy in cancer patients
64. Alloimmunization to RhD by platelet transfusions in autologous bone marrow transplant recipients
65. Are Rh antigens restricted to red cells?
66. Immunoprophylaxis using intravenous Rh immune globulin should be standard practice when selected D-negative patients are transfused with D-positive random donor platelets